NSAID Use After Robotic Partial Nephrectomy
Trial statusRecruiting
Trial phasePhase 2
Trial typeInterventional
Biological sexAll
Age18-99
SponsorUniversity of Miami
About this trial
The purpose of this study is to see how effective non-steroidal anti-inflammatory drugs (NSAIDs) are at controlling pain without side effects in participants after robotic-assisted partial nephrectomy.
Eligibility criteria
Qualifiers
Patients undergoing uncomplicated robotic assisted laparoscopic partial nephrectomy for renal mass at the University of Miami Hospital and Network Sites (Deerfield Beach, Plantation, Lennar (Coral Gables), and Kendal).
Age 18-99.
Ability to understand and the willingness to sign a written informed consent document.
Disqualifiers
Allergy to NSAIDs
Myocardial infarction or unstable angina within 12 months.
Any history of coronary artery bypass graft surgery.
History or active peptic ulcer disease, gastrointestinal (GI) bleeding, GI perforation. History of bleeding disorder. Glomerular filtration rate (GFR) < 60 mL/min/1.73m2 (Modification of Diet in Renal Disease (MDRD) equation).
Trial design
Treatments tested in this trial
- Ketorolac
- Acetaminophen
- Oxycodone
- Hydromorphone
- Ibuprofen
Treatment groups
110 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov